SCHEMBL3292185

SCHEMBL3292185

CCc1nc2cc(F)ccc2n1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
HTT P42858 2/20 0.58
USP2 O75604 2/20 0.58
TSHR P16473 1/20 0.58
HDAC1 Q13547 1/20 0.51
CPT1A P50416 1/20 0.50
HTR3E A5X5Y0 1/20 0.49
HTR3B O95264 1/20 0.49
HTR3A P46098 1/20 0.49
HTR3D Q70Z44 1/20 0.49
HTR3C Q8WXA8 1/20 0.49
DRD2 P14416 2/20 0.48
DRD4 P21917 2/20 0.48
DRD3 P35462 2/20 0.48
CCR3 P51677 2/20 0.48
KMT2A Q03164 1/20 0.47
FPR2 P25090 1/20 0.47
NPSR1 Q6W5P4 2/20 0.45
MAPT P10636 1/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5393257 0.87 CCR3 (0.65) ALDH1A1HTTUSP2TSHRHDAC1
Hydrochloric Acid SCHEMBL31587217 0.87 USP2 (0.47) ALDH1A1HTTUSP2TSHRHDAC1
Hydrochloric Acid SCHEMBL5382308 0.86 CCR3 (0.64) ALDH1A1HTTUSP2TSHRHDAC1
SCHEMBL5773446 0.84 ALDH1A1 (0.62) ALDH1A1HTTUSP2TSHRHDAC1
SCHEMBL5377302 0.81 ALDH1A1 (0.58) ALDH1A1HTTUSP2TSHRHDAC1
SCHEMBL3995292 0.80 ALDH1A1 (0.54) ALDH1A1HTTUSP2TSHRDRD2
SCHEMBL17512052 0.79 ALDH1A1 (0.55) ALDH1A1HTTUSP2TSHRHDAC1
SCHEMBL16128201 0.79 ALDH1A1 (0.55) ALDH1A1HTTUSP2TSHRHDAC1
SCHEMBL13319401 0.78 CYP3A4 (0.54) ALDH1A1HTTCPT1AFPR2MAPT
SCHEMBL3292500 0.78 CCR3 (0.74) ALDH1A1HTTHDAC1CPT1ACCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723360-B2 Alkyl-and piperidine-substituted benzimidazole derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-05-25 US disclosed
US-7723360-B2 Alkyl-and piperidine-substituted benzimidazole derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-05-25 US disclosed
US-7723360-B2 Alkyl-and piperidine-substituted benzimidazole derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-05-25 US disclosed
EP-1776356-B1 ALKYL-AND PIPERIDINE-SUBSTITUTED BENZIMIDAZOLE-DERIVATES BOEHRINGER INGELHEIM INT (DE) 2008-09-17 EP disclosed
EP-1776356-B1 ALKYL-AND PIPERIDINE-SUBSTITUTED BENZIMIDAZOLE-DERIVATES BOEHRINGER INGELHEIM INT (DE) 2008-09-17 EP disclosed
EP-1776356-A1 ALKYL-AND PIPERIDINE-SUBSTITUTED BENZIMIDAZOLE-DERIVATES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-25 EP disclosed
WO-2006013073-A1 ALKYL-AND PIPERIDINE-SUBSTITUTED BENZIMIDAZOLE-DERIVATES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-02-09 WO disclosed
US-20060030590-A1 Alkyl-and piperidine-substituted benzimidazole derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030590-A1 Alkyl-and piperidine-substituted benzimidazole derivatives ABCB11, KCNJ11, ABCB1 ALDH1A1 141/4885HTT 1873/4885USP2 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.